Company ProfilePremium

SPR Therapeutics

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
SPR Therapeutics - Healthcare showcase

Year Founded & Workforce

2010

200 Employees

Industry

Healthcare

Services

Peripheral Nerve Stimulators
S

SPR Therapeutics Employee Contacts

7 verified contactsNames, job titles, seniority and locations

View Employee Contacts

SPR Therapeutics Overview

Company Headquarters: Ohio, US

Founded: 2010

Workforce: ~200

Company Working: SPR Therapeutics is a medical device company which is engaged in the development and sales of non-opioid, minimally invasive products. The company provides non-narcotic, reversible, effective, safe, and economically alternatives to addictive invasive surgeries and opioid medication for pain management cases. The company specializes in medical devices, pain therapy, pain management, therapeutic technology, pain management neurostimulation products, and others. The company distributes its products in the North America region.

Strategy

SPR Therapeutics focused on the development of high-quality products to meet customer demand across the globe. The company emphasizes expanding manufacturing facilities to develop products as well as continue to improve customer outcomes. It is also focused on extending its distribution network in the region to increase its market share and revenue.

Company Snapshot

200

Employees

2010

Founded

Ohio, US

Headquarters

Key Developments

DateApproachDevelopment
August 2018ApprovalSPR Therapeutics received US FDA product approval for SPRINT PNS system. This product provides relief in both chronic and acute pain conditions. By this product launch company expand their product portfolio in North America region.

Product Offering

  • SPR Therapeutics
    • Peripheral Nerve Stimulators

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.